The global cell and tissue preservation market covers equipment, consumables, and media used for cryopreservation and preservation of cells and tissues. Cell & tissue preservation allows long-term storage of biological samples at ultra-low temperatures for future application in research activities, clinical diagnostics, and cell & tissue-based therapies. Cell preservation equipment help in controlled freezing and thawing required for cryopreservation of samples, while consumables are one-time use containers and media are solutions required for storage of biological materials. The increasing research in application of stem cells for disease treatment and growing demand for biobanking are fueling the need for cell & tissue preservation products.
Global Cell And Tissue Preservation Market is estimated to be valued at USD 5.11 Bn in 2024 and is expected to reach USD 10.82 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 11.3% from 2024 to 2031.
Key Takeaways
Key players operating in the global cell and tissue preservation market are Thermo Fisher Scientific, Inc., Lonza, BD, MerckKGaA, Cytiva, Agilent Technologies, Inc., Avantor, Inc., FUJIFILM Irvine Scientific, BioLifeSolutions Inc., AMSBIO, Princeton CryoTech, STEMCELL Technologies Inc., LGC SeraCare, Corning Incorporated, CellGenix GmbH.
The global cell and tissue preservation market has seen rising demand due to increasing research in stem cell therapy and regenerative medicines. The number of clinical trials has increased multi-fold over the last decade. Preservation is vital for storage and transportation of biological samples used in these research studies and clinical applications.
Technological advancements in cryopreservation process, equipment, and storage solutions are also fueling the Global Cell And Tissue Preservation Market Size. Automated freezing and controlled rate freezing equipment offer standardization and improve sample viability. Newer biomaterials provide better tissue preservation and enhance the capabilities of biobanks to store various sample types.
Market trends:
- Increased adoption of automated cell and tissue processing: Automation reduces manual errors and improves throughput and standardization in preservation workflow.
- Growing preference for serum-free and animal-component free solutions: Developments are underway to address end-user demand for xeno-free formulations to avoid contamination.
Market Opportunities:
- Emerging economies in Asia Pacific and Latin America: Improving research infrastructure and increasing healthcare investments provide lucrative opportunities.
- Umbilical cord blood and tissue banking: Expanding network of private and public banks worldwide augments demand for specialized preservation solutions.
Impact of COVID-19 on Global Cell and Tissue Preservation Market Growth
The outbreak of COVID-19 pandemic has significantly impacted the growth of Global Cell and Tissue Preservation Market Regional Analysis. During the initial lockdown period, hospitals and research institutes experienced supply chain disruptions as transportation restrictions were imposed globally. This led to shortage of raw materials such as preservation media for cell and tissue culture preservation. However, with increased focus on vaccine development and clinical testing, demand for preserved cell and tissue samples grew exponentially. Manufacturers responded swiftly by scaling up their production capacities and supply chains. Government funding for COVID-19 research also boosted the procurement of preservation products and equipment by biotech and pharmaceutical companies.
Post lockdown, the market has witnessed growing demand from biobanks for long term preservation of COVID-19 testing samples as well as various cell lines used in vaccine development studies. The need to store clinical samples for future analysis has accelerated the adoption of automated banking equipment by government organizations. Moving forward, sustained research on virus pathogenesis and development of combination therapies will further augment the requirement for preserved biomaterials. Additionally, cell and tissue transplantation procedures deferred during peak pandemic period are being resumed, contributing to market revenues. Overall, COVID-19 has enhanced the significance of cell and tissue biobanking globally.
Concentration of Global Cell and Tissue Preservation Market based on Geographical Regions
In terms of value, the North America region holds the largest share of the global cell and tissue preservation market currently. This is attributed to strong government funding for biomedical research in the United States. Increasing allocation towards development of cell-based therapies and vaccine research has prompted leading biopharma companies and academic institutes to invest heavily in high-quality preservation equipment, media and tools. Additionally, presence of numerous biobanks engaged in COVID-19 sample collection ensures steady demand from this region over the forecast period.
Fastest Growing Region in the Global Cell and Tissue Preservation Market
The Asia Pacific region is poised to exhibit the fastest growth in the global cell and tissue preservation market during the projected time period. This can be accredited to expanding biopharmaceutical industry, rising healthcare expenditure, and growing geriatric populationacross major countries like China and India. Further, supportive government initiatives to develop local biotech sectors through funding and infrastructure development are encouraging international players to establish manufacturing and R&D facilities in the region. All these factors are expected to drive significant market opportunities for cell and tissue preservation products in Asia Pacific.
Get more insights on Global Cell And Tissue Preservation Market
COVID-19 Impact Analysis on Organ and Tissue Transplantation Market report published by Value Market Research provides a detailed market analysis comprising market size, share, value, growth and trends for the period 2020-2027.
Moreover, this market report also covers regional and country markets in detail.The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide.
The major players in the organ and tissue transplantation market include NHS Blood and Transplant, Tissue Services, U.K., LifeCell Corporation, Mid-America Transplant Services, Australian Red Cross Blood Service, Acelity L.P. Inc., CryoLife, Inc., Exactech Inc., Folio Biosciences, LLC Dr. Franz Kohler Chemie GmbH, etc.
This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.Get more information on "Global Organ and Tissue Transplantation Market Research Report" by requesting FREE Sample Copy at https://www.valuemarketresearch.com/contact/organ-and-tissue-transplantation-market/download-sampleMarket DynamicsThe global organ and tissue transplantation market is expanding with the consequences of the rising burden of non-communicable diseases, geriatric population, and other risk exposures.
High incidence and prevalence of diseases such as cardiovascular diseases, diabetes, cancer, renal diseases, and Alzheimer’s disease most probably cause organ failure to contribute to the growing market revenue.
However, the high cost of the procedure, lack of donors, and threat of implant failure are restraining the worldwide organ and tissue transplantation market growth.’The research report covers Porter’s Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis.
Organ and tissue disappointment is generally hopeless and prompts lifetime dependence on leads on prescriptions.
In such genuine conditions, transfers stay the spine for a revamping of solid life.
For what it's worth, there has been a flood in tissue relocation with progress in clinical biotechnology.
A Large populace of the world faces the high commonness of sicknesses like cardiovascular infections, diabetes, malignant growth, renal illnesses, and Alzheimer's sickness, and so forth which could be the justification organ and tissue disappointment.
As per WHO, all around the world, more than millions, new cases and a few million disease-related passing were recorded in 2012.
Because of expanding frequency and commonness of constant sickness and high transplantation endurance achievement rate offers the appeal of tissue and organ transplantation administrations.
